Evidence map›Paper›PMID 20943973›Full record

ArticleJournal of virology2010

Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.

Rachel A Katzenellenbogen, Portia Vliet-Gregg, Mei Xu, Denise A Galloway

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c.International journal of clinical and experimental pathology · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rachel A KatzenellenbogenDepartment of Pediatrics, University of Washington, Seattle, Washington, USA. rkatzen@uw.edu
Portia Vliet-Gregg
Mei Xu
Denise A Galloway
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

University of Washington STI-TM Cooperative Research CtrU19AI031448 · NIAID · UNIVERSITY OF WASHINGTON · PI HOLMES, KING K. · 1995 to 2010
$15.2M
INTERACTIONS OF HPV ONCOGENES WITH THE P53 PATHWAYR01CA064795 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GALLOWAY, DENISE A. · 1995 to 2017
$8.6M
Regulation of Telomerase by NFX1K08CA131171 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI KATZENELLENBOGEN, RACHEL ADRIA · 2008 to 2012
$672k
NCI NIH HHS K08 CA131171NCI NIH HHS K08 CA131171-01NCI NIH HHS R01 CA064795NIAID NIH HHS U19 AI031448NIAID NIH HHS U19 AI 31448
6 · The paper itself

Abstract

The high-risk human papillomavirus (HPV) E6 and E7 oncoproteins are critical to the immortalization of keratinocytes. HPV type 16 (HPV16) E6 interacts with endogenous proteins to activate hTERT, the catalytic subunit of telomerase, thus avoiding cellular senescence signals. NFX1-123, the longer splice variant of NFX1, interacts with HPV16 E6, as well as cytoplasmic poly(A) binding proteins 1 and 4 (PABPC1 and PABPC4). HPV16 E6 affects hTERT expression posttranscriptionally through NFX1-123, as NFX1-123 interacts with hTERT mRNA and stabilizes it, leading to greater telomerase activity. The PAM2 motif of NFX1-123, with which it binds PABPCs, is required for the posttranscriptional regulation of hTERT by HPV16 E6 and NFX1-123. There is increasing evidence that RNA and DNA viruses utilize RNA-processing proteins, and specifically PABPCs, in the normal virus life cycle, and there is also evidence that RNA-processing proteins are perturbed in cancers. Here, we show that PABPCs are critical in hTERT regulation by HPV16 E6. Although the amount and cellular localization of PABPCs were largely unchanged in cervical cancer cell lines with or without HPV16 and in human foreskin keratinocytes (HFKs) with or without HPV16 E6, knockdown of PABPCs decreased hTERT mRNA and telomerase activity and overexpression of PABPC4 increased these in HPV16 E6-expressing HFKs. In contrast, knockdown of PABPCs in C33A cells had no effect on hTERT mRNA or telomerase activity. Additionally, overexpression of PABPC4 and hTERT led to greater growth of cultured HPV16 E6-expressing HFKs. This is the first evidence that PABPCs have a targeted role in hTERT regulation leading to a growth advantage in cells expressing HPV16 E6.

Indexed as

Blood ProteinsBlotting, WesternCell ProliferationCells, CulturedCervix UteriFemaleForeskinHuman papillomavirus 16HumansKeratinocytesMaleOncogene Proteins, ViralPapillomavirus InfectionsPoly(A)-Binding Protein IPoly(A)-Binding ProteinsPromoter Regions, GeneticBlood ProteinsE6 protein, Human papillomavirus type 16NFX1 protein, humanOncogene Proteins, ViralPABPC4 protein, humanPoly(A)-Binding Protein IPoly(A)-Binding ProteinsRepressor ProteinsRNA, MessengerTelomeraseTERT protein, human

Identifiers

PMID20943973
PMCPMC3004306
OpenAlexW2124177978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.